Search Results

Business

VisionGate, Inc. Appoints R. John Glasspool as Chief Operating and Strategy Officer and member of the Board of Directors

VisionGate, Inc. is pleased to announce the appointment of R. John Glasspool as its Chief Operating and Strategy Officer.

October 18, 2018

·

5 min read

BioForest

VisionGate’s Cell-CT™ Platform Uses 3D Cell Morphometry and Artificial Intelligence to Detect an Immunotherapy Predictive Biomarker and Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC) from Liquid Biopsy

Breakthrough Research to be Presented at the 2018 World Conference on Lung Cancer

September 26, 2018

·

9 min read

Deals

VisionGate Eyes IPO and Plans to Hire 200 New Employees

July 16, 2015

·

1 min read

BioMidwest

VisionGate’s First Product, LuCED, Shows Promise For Screening Of Lung Cancer

September 8, 2015

·

5 min read

Breakthrough Research to be Presented at the 2018 World Conference on Lung Cancer

VisionGate, a clinical stage oncology pharmaceutical and diagnostics company announces two peer-reviewed poster presentations at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC), 23-26 September in Toronto, Canada.

September 27, 2018

·

9 min read

BioMidwest

Making LIFE Better: VisionGate Receives AZBio Fast Lane Honors

September 22, 2015

·

4 min read

BioMidwest

VisionGate Release: Significant Lung Cancer Screening Study Published In The American Cancer Society Journal, Cancer Cytopathology

July 7, 2015

·

4 min read

BioMidwest

VisionGate To Present Early Lung Cancer Detection Data At American Society of Clinical Oncology

May 7, 2014

·

1 min read

Data Shows VisionGate’s 3D Imaging Platform Accurately Detects Lung Cancer in Sputum

October 28, 2013

·

1 min read

BioMidwest

New Study Shows High Sensitivity And Specificity For VisionGate’s Luced® Test To Help Detect Lung Cancer Earlier

May 15, 2014

·

1 min read